No Data
No Data
Navigating Uncertainty: How Global Crises Threaten Sensus Healthcare's Growth and Operations
Sensus Healthcare to Participate in the 36th Annual Roth Conference
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces management will participate in one-on-one or small group meetings with institutional investors at the 36th Annual Roth conference to be held March 17th – 19th in Dana Point, Calif.
Sensus Healthcare Launches "Fair Deal Agreement" for Its SRT-100 Vision at the American Academy of Dermatology Annual Meeting
Sensus Healthcare, Inc. (Nasdaq: SRTS) announces the successful launch of its new "Fair Deal Agreement" for the SRT-100 Vision (IG-SRT) at the AAD 2024 Annual Meeting, held March 8-12 in San Diego.
SkinCure Oncology Unveils New Skin Cancer Treatment Technology at American Academy of Dermatology Annual Meeting in San Diego March 8-12 Booth 3555
BURR RIDGE, Ill., March 07, 2024 (GLOBE NEWSWIRE) -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT or IGSRT) for
T2 Biosystems, AMN Healthcare Services Among Healthcare Movers
Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating
No Data